News from NORD

More Than 100 Patient Organizations Join NORD in Supporting the RARE Act


 

NORD has sent a letter to Congress, signed by more than 100 patient advocacy organizations, in support of the Rare Disease Advancement, Research, and Education Act of 2018 (H.R.5115) or the “RARE Act of 2018.” Read NORD’s letter to see how this proposed legislation would help patients and families affected by rare diseases, medical researchers, and clinicians seeking to provide optimal care for their patients.

Recommended Reading

FDA approves burosumab to treat X-linked hypophosphatemia
MDedge Pediatrics
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Pediatrics
Intraventricular enzyme replacement slows CLN2 disease progression
MDedge Pediatrics
Colchicine looks promising for treating prurigo pigmentosa in case report
MDedge Pediatrics
Intrauterine therapy showed promise in XLHED
MDedge Pediatrics
Low incidence of HS in children does not diminish importance of early diagnosis
MDedge Pediatrics
Collagen remodeling observed after laser treatment in EB patient
MDedge Pediatrics
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Pediatrics
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Pediatrics
RFPs Available for the Study of Three Rare Diseases
MDedge Pediatrics